P.Y. Scarabin

567 total citations
19 papers, 433 citations indexed

About

P.Y. Scarabin is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P.Y. Scarabin has authored 19 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P.Y. Scarabin's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Blood properties and coagulation (3 papers) and Retinal Diseases and Treatments (3 papers). P.Y. Scarabin is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Blood properties and coagulation (3 papers) and Retinal Diseases and Treatments (3 papers). P.Y. Scarabin collaborates with scholars based in France, United Kingdom and Australia. P.Y. Scarabin's co-authors include M Samama, Dominique Arveiler, Giang Huong Nguyen, Mats Rånby, L. Bara, Viviane Nicaud, A. Evans, Adriano Henney, Sally J. Dawson and G. Luc and has published in prestigious journals such as Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis and Thrombosis Research.

In The Last Decade

P.Y. Scarabin

19 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.Y. Scarabin France 8 225 144 133 115 77 19 433
D C Rijken Belgium 13 290 1.3× 279 1.9× 101 0.8× 182 1.6× 57 0.7× 14 605
B Lombardi Italy 4 130 0.6× 60 0.4× 125 0.9× 148 1.3× 92 1.2× 4 360
J Valadier France 5 289 1.3× 256 1.8× 119 0.9× 241 2.1× 91 1.2× 7 650
Fletcher Ap United States 10 131 0.6× 82 0.6× 52 0.4× 156 1.4× 32 0.4× 16 414
Kousuke Kumeda Japan 13 447 2.0× 68 0.5× 331 2.5× 87 0.8× 135 1.8× 21 758
Sarra Saidi Tunisia 13 156 0.7× 62 0.4× 88 0.7× 30 0.3× 37 0.5× 16 388
Mariëlle J. Tempelman Netherlands 8 316 1.4× 48 0.3× 70 0.5× 53 0.5× 48 0.6× 9 459
Corinna Böttiger Germany 13 171 0.8× 33 0.2× 310 2.3× 93 0.8× 248 3.2× 16 691
Charles G. Pearce United States 10 150 0.7× 70 0.5× 130 1.0× 187 1.6× 177 2.3× 14 543
I Canavy France 6 69 0.3× 55 0.4× 148 1.1× 94 0.8× 97 1.3× 10 422

Countries citing papers authored by P.Y. Scarabin

Since Specialization
Citations

This map shows the geographic impact of P.Y. Scarabin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.Y. Scarabin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.Y. Scarabin more than expected).

Fields of papers citing papers by P.Y. Scarabin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.Y. Scarabin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.Y. Scarabin. The network helps show where P.Y. Scarabin may publish in the future.

Co-authorship network of co-authors of P.Y. Scarabin

This figure shows the co-authorship network connecting the top 25 collaborators of P.Y. Scarabin. A scholar is included among the top collaborators of P.Y. Scarabin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.Y. Scarabin. P.Y. Scarabin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ryan, Joanne, Jacqueline Scali, Isabelle Carrière, et al.. (2011). FC23-03 - Estrogen receptor polymorphisms and late-life depression. European Psychiatry. 26(S2). 1941–1941. 1 indexed citations
2.
Verstuyft, Céline, Marianne Canonico, Élodie Bouaziz-Amar, Anne Guiochon‐Mantel, & P.Y. Scarabin. (2009). VKORC1 genetic polymorphism and risk of venous thromboembolism in postmenopausal women: new findings and meta-analysis. Journal of Thrombosis and Haemostasis. 7(6). 1034–1036. 1 indexed citations
3.
Morange, Pierre‐Emmanuel, P.Y. Scarabin, Marie‐Christine Alessi, et al.. (2003). Association between TAFI antigen and Ala l47Thr polymorphism of the TAFI gene and the angina pectoris incidence. Thrombosis and Haemostasis. 89. 554–560. 47 indexed citations
4.
Oger, Emmanuel, Karine Lacut, & P.Y. Scarabin. (2002). Thrombose veineuse profonde : épidemiologie, facteurs de risque acquis. Annales de Cardiologie et d Angéiologie. 51(3). 124–128. 3 indexed citations
5.
Marques‐Vidal, Pedro, Barbara Haas, A. Bingham, et al.. (2000). Association of hypertensive status and its drug treatment with lipid and haemostatic factors in middle-aged men: the PRIME Study. Journal of Human Hypertension. 14(8). 511–518. 12 indexed citations
6.
7.
Scarabin, P.Y., et al.. (1991). 90326019 Relationship between plasminogen activator inhibitor activity and menopausal status. Maturitas. 13(2). 175–175. 1 indexed citations
8.
Bonithon‐Kopp, Claire, P.Y. Scarabin, Bernadette Darné, A Malméjac, & L Guize. (1990). 90127180 Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Maturitas. 12(4). 368–368. 3 indexed citations
9.
Lecrubier, C, et al.. (1990). Does Increased Platelet Aggregation Have a Prognostic Value in the Deterioration of Background Diabetic Retinopathy?. Thrombosis and Haemostasis. 64(2). 202–205. 2 indexed citations
10.
Rånby, Mats, Giang Huong Nguyen, P.Y. Scarabin, & M Samama. (1989). Immunoreactivity of Tissue Plasminogen Activator and of Its Inhibitor Complexes. Thrombosis and Haemostasis. 61(3). 409–414. 77 indexed citations
11.
Bonithon‐Kopp, Claire, et al.. (1988). Menopause-related change in plasma viscosity. Clinical Hemorheology and Microcirculation. 8(3-4). 525–531. 7 indexed citations
12.
Scarabin, P.Y., et al.. (1987). Reliability of a single beta-thromboglobulin measurement in a diabetic population: importance of PGE1 in anticoagulant mixture. Damad Study Group.. PubMed. 57(2). 201–4. 1 indexed citations
13.
Scarabin, P.Y., Claire Bonithon‐Kopp, L. Bara, M Samama, & P Blot. (1987). Is factor VII activation in pregnant women relevant to fetal growth retardation?. Thrombosis Research. 45(6). 845–850. 6 indexed citations
14.
Scarabin, P.Y., et al.. (1987). Reliability of a Single β-Thromboglobulin Measurement in a Diabetic Population : Importance of PGE1 in Anticoagulant Mixture. Thrombosis and Haemostasis. 57(2). 201–204. 1 indexed citations
15.
Scarabin, P.Y., et al.. (1985). A Multicenter Study on Amidolytic Factor X Evaluation in Oral Anticoagulant Therapy. Thrombosis and Haemostasis. 53(3). 433–436. 2 indexed citations
16.
Scarabin, P.Y. & M Samama. (1981). Damad study research group : Effect of age on ADP-induced platelet aggregation in diabetic and non-diabetic subjects. Thrombosis Research. 22(5-6). 687–692. 7 indexed citations
17.
Lecrubier, C, P.Y. Scarabin, F. Grauso, & M Samama. (1980). Platelet Aggregation Related to Age in Diabetes Mellitus. Pathophysiology of Haemostasis and Thrombosis. 9(1). 43–51. 12 indexed citations
18.
Conard, J., C Lecrubier, P.Y. Scarabin, et al.. (1980). Effects of long term administration of ticlopidine on platelet function and hemostatic variables. Thrombosis Research. 20(1). 143–148. 43 indexed citations
19.
Lecrubier, C, et al.. (1979). Platelet Aggregation Related to age in Diabetes Mellitus. Thrombosis and Haemostasis. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D C Rijken Breakdown of academic impact, for papers by B Lombardi Breakdown of academic impact, for papers by J Valadier Breakdown of academic impact, for papers by Fletcher Ap Breakdown of academic impact, for papers by Kousuke Kumeda Breakdown of academic impact, for papers by Sarra Saidi Breakdown of academic impact, for papers by Mariëlle J. Tempelman Breakdown of academic impact, for papers by Corinna Böttiger Breakdown of academic impact, for papers by Charles G. Pearce Breakdown of academic impact, for papers by I Canavy
Rankless by CCL
2026